Clinical Trial Update: Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated neoadjuvant chemoradiotherapy with or without gefitinib in patients with Stage IIIA or IIIB non-small cell lung cancer, and the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED